Debrief from Pharmapack Europe 2021
21 October 2021
Photo courtesy of Informa PLC We were excited to attend Pharmapack Europe 2021 last week, it being perhaps the first…
Springboard will attend Pharmapack Europe 2021
11 October 2021
Springboard is excited to be attending Pharmapack Europe 2021, where we will announce a novel approach to minimising…
What are the challenges facing gene therapies?
24 June 2021
Gene therapies are at the forefront of medical science, looking to treat the rarest of diseases that collectively afflict millions…
Is your drug damaged? Particle counting can give you the answer
20 January 2021
Safety and efficacy of drugs are top priorities. However, biologic drugs are sensitive molecules, and they can be damaged easily,…
Drug delivery trends for 2021
16 December 2020
Drug delivery devices are evolving rapidly, and Springboard is in the privileged position of being at the centre of developing…
Development of a new high-performance autoinjector
3 April 2020
Prefilled syringes have become the standard format for delivering new biologic drugs. However, they suffer from various issues, such as:…
Springboard offers medical device expertise to tackle COVID-19
24 March 2020
One of Springboard’s three motivations is to help peoples’ lives around the world. The current pandemic of COVID-19 is concerning…
Let the patient decide: an autoinjector with patient-settable injection time
24 September 2018
Autoinjectors have to inject the drug within a reasonable range of time. The minimum injection time is set by potential…
Nanopatterning for medical applications
6 September 2018
Nanotechnology appears in popular culture as a cure for everything from cancer to balding. In science nanotechnology is an umbrella…